STRATA Skin Sciences, Inc. (NASDAQ:SSKN – Get Free Report) saw a large decline in short interest during the month of April. As of April 15th, there was short interest totalling 157,200 shares, a decline of 27.0% from the March 31st total of 215,200 shares. Approximately 0.9% of the shares of the stock are sold short. Based on an average daily volume of 26,000 shares, the short-interest ratio is presently 6.0 days.
Hedge Funds Weigh In On STRATA Skin Sciences
Several institutional investors and hedge funds have recently added to or reduced their stakes in SSKN. Chicago Partners Investment Group LLC grew its holdings in shares of STRATA Skin Sciences by 162.0% during the 4th quarter. Chicago Partners Investment Group LLC now owns 64,223 shares of the medical device company’s stock valued at $33,000 after acquiring an additional 39,706 shares in the last quarter. Azzad Asset Management Inc. ADV boosted its position in STRATA Skin Sciences by 289.5% during the first quarter. Azzad Asset Management Inc. ADV now owns 67,000 shares of the medical device company’s stock worth $25,000 after purchasing an additional 49,800 shares during the period. Finally, 22NW LP boosted its holdings in shares of STRATA Skin Sciences by 56.1% during the 3rd quarter. 22NW LP now owns 5,369,954 shares of the medical device company’s stock worth $3,195,000 after buying an additional 1,930,693 shares during the period. 32.43% of the stock is currently owned by hedge funds and other institutional investors.
STRATA Skin Sciences Price Performance
NASDAQ:SSKN traded down $0.08 during trading hours on Monday, reaching $0.43. 63,534 shares of the company’s stock were exchanged, compared to its average volume of 31,906. The company has a quick ratio of 1.06, a current ratio of 1.28 and a debt-to-equity ratio of 1.19. The company has a market capitalization of $15.08 million, a P/E ratio of -1.39 and a beta of 1.58. STRATA Skin Sciences has a 12 month low of $0.26 and a 12 month high of $1.14. The business’s 50-day simple moving average is $0.50 and its two-hundred day simple moving average is $0.51.
STRATA Skin Sciences (NASDAQ:SSKN – Get Free Report) last announced its earnings results on Wednesday, March 27th. The medical device company reported ($0.04) EPS for the quarter. The firm had revenue of $8.69 million during the quarter. STRATA Skin Sciences had a negative return on equity of 52.50% and a negative net margin of 32.47%. Sell-side analysts expect that STRATA Skin Sciences will post -0.19 EPS for the current fiscal year.
About STRATA Skin Sciences
STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.
Further Reading
- Five stocks we like better than STRATA Skin Sciences
- What is a Special Dividend?
- The 3 Hottest Insiders Buys This Month
- 5 discounted opportunities for dividend growth investors
- What Bulls and Bears May Be Getting Wrong about SOFI Stock
- Canada Bond Market Holiday: How to Invest and Trade
- Microsoft Analysis: Trends, Predictions & Investment Insight
Receive News & Ratings for STRATA Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRATA Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.